People

Upon completing my PhD defense (2023.05) and an interim postdoctoral period at Karolinska Institutet, I conducted my postdoctoral training at the University of California, San Francisco (2024–2026). My research primarily focuses on the cellular and molecular mechanisms underlying white matter pathology, with a particular emphasis on the role of microglia in regulating myelin health, damage, and repair. White matter abnormalities and demyelination are common in aging and neurological diseases such as multiple sclerosis, neuromyelitis optica, and Alzheimer’s disease; however, effective strategies to reinforce myelin health and neuronal resilience remain limited. By combining cutting-edge omics, advanced imaging, state-of-the-art mouse genetic tools, immunophenotyping, and toolboxes for manipulating glial function, I aim to establish a mechanistic and translational framework for understanding and fine-tuning microglia-myelin and microglia-neuron interactions in aging and disease, as well as to provide in-depth insights and therapeutic strategies for restoring CNS resilience and combating neurological disorders. As the main applicant, I received funding support from the Swedish Research Council (Vetenskapsrådet), the Swedish Society for Medical Research (SSMF), the Swedish MS Research Foundation (MS-forskningsfonden), the Swedish Neuro Foundation (Neurofonden), and Erik and Edith Fernström Foundation, totaling around $800K. I have served as an ad hoc reviewer for more than 30 manuscripts for journals including Nature Neuroscience, Advanced Science, eLife, Cell Death & Disease, Translational Neurodegeneration, and Neurobiology of Disease. By invitation, I serve as a Guest Editor for Frontiers in Immunology, Frontiers in Cellular Neuroscience, and Journal of Leukocyte Biology.